EUCTR2015-001077-40-FI进行中（未招募）1 期
INNOVATIVE STEROID TREATMENT TO REDUCE ASTHMA DEVELOPMENT IN CHILDREN AFTER FIRST-TIME RHINOVIRUS INDUCED WHEEZING – THE INSTAR STUDY - INSTAR
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1) Age 3-23 months,
- •2) first acute severe wheezing episode,
- •3) rhinovirus positive PCR-test in nasopharyngeal aspirate, and
- •4) written informed consent.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 280
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Chronic illness other than atopy,
- •2) previous systemic or inhaled corticosteroid treatment,
- •3) participation to another trial,
- •4) varicella contact if previously intact, or
- •5) need for intensive care unit treatment.
研究者
相似试验
进行中（未招募）
1 期
Asthma prevention in high-risk children by using early corticosteroid interventioFirst acute wheezing episodeEUCTR2015-001077-40-SESt. Olavs Hospital280
进行中（未招募）
1 期
Asthma prevention in high-risk children by using early corticosteroid interventioFirst acute wheezing episodeEUCTR2015-001077-40-NOSt Olavs Hospital HF280
招募中
4 期
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced WheezingInflammationAsthmaNCT03889743St. Olavs Hospital280
已完成
不适用
Options to control asthma by means of a newly developed FeNO device for use at homeAsthmaJ45DRKS00029118Bosch Healthcare Solutions GmbH87
已完成
不适用
Asthma Reduction with Inhaled corticoSteroids in Children with a high risk for the development of asthma (At RISC)AsthmaISRCTN58244066Care and Public Health Research Institute (CAPHRI), University Maastricht (Netherlands)97